Close Menu

NEW YORK (360Dx) – Quest Diagnostics today announced that it has signed a definitive agreement to acquire the assets of the clinical lab services business of Boyce and Bynum Pathology Laboratories (BBPL).

The relationship between Quest and BBPL, which is based in Columbia, Missouri and serves the Midwest, will result in a broader menu of clinical laboratory and anatomic pathology services throughout the region, according to a Quest statement. The relationship will also give patients access to an expanded network of service centers across the Midwest for greater convenience.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
05
Sponsored by
Amazon

The discovery of microbial cell-free DNA has propelled the introduction of new technologies that can be leveraged for next-generation diagnostic assays. Previously inaccessible genomic information can now be comprehensively surveyed for microorganisms, all from a single blood draw.

Dec
10
Sponsored by
Congenica II

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.